全文获取类型
收费全文 | 17489篇 |
免费 | 1837篇 |
国内免费 | 431篇 |
专业分类
耳鼻咽喉 | 687篇 |
儿科学 | 336篇 |
妇产科学 | 190篇 |
基础医学 | 2371篇 |
口腔科学 | 131篇 |
临床医学 | 1943篇 |
内科学 | 1567篇 |
皮肤病学 | 217篇 |
神经病学 | 599篇 |
特种医学 | 861篇 |
外国民族医学 | 16篇 |
外科学 | 2867篇 |
综合类 | 3216篇 |
预防医学 | 659篇 |
眼科学 | 253篇 |
药学 | 1085篇 |
16篇 | |
中国医学 | 336篇 |
肿瘤学 | 2407篇 |
出版年
2024年 | 28篇 |
2023年 | 301篇 |
2022年 | 512篇 |
2021年 | 857篇 |
2020年 | 882篇 |
2019年 | 707篇 |
2018年 | 678篇 |
2017年 | 759篇 |
2016年 | 860篇 |
2015年 | 807篇 |
2014年 | 1327篇 |
2013年 | 1134篇 |
2012年 | 1002篇 |
2011年 | 1087篇 |
2010年 | 835篇 |
2009年 | 701篇 |
2008年 | 782篇 |
2007年 | 761篇 |
2006年 | 688篇 |
2005年 | 580篇 |
2004年 | 470篇 |
2003年 | 451篇 |
2002年 | 373篇 |
2001年 | 339篇 |
2000年 | 312篇 |
1999年 | 252篇 |
1998年 | 253篇 |
1997年 | 220篇 |
1996年 | 174篇 |
1995年 | 181篇 |
1994年 | 156篇 |
1993年 | 159篇 |
1992年 | 120篇 |
1991年 | 116篇 |
1990年 | 95篇 |
1989年 | 77篇 |
1988年 | 76篇 |
1987年 | 64篇 |
1986年 | 84篇 |
1985年 | 81篇 |
1984年 | 61篇 |
1983年 | 39篇 |
1982年 | 50篇 |
1981年 | 62篇 |
1980年 | 42篇 |
1979年 | 30篇 |
1978年 | 33篇 |
1977年 | 33篇 |
1976年 | 18篇 |
1975年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 332 毫秒
51.
正常及良性前列腺增生组织中表皮生长因子活性的测定 总被引:3,自引:0,他引:3
为了解表皮生长因子在前列腺组织中的作用,利用免疫组织化学方法和竟争放射受体法对人正常和良性前列腺增生组织中表皮生长因子的组织定位和活性进行了检测。结果表明表皮生长因子主要定位于前列腺的分泌上皮细胞,正常前列腺和良性前列腺增生组织中表皮生长因子的活性无显著性差异。提示前列腺组织中表皮生长因子的主要作用可能并非在于调节前列腺上皮细胞的增殖。 相似文献
52.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
53.
对雄性Wisiaf大鼠腹腔1次注射碘-13l, 注入活度分别为0.59×104Bq,2.37×104Bq, 4.34×104Bq, 8.23×104Bq, 碘-125注入活度分别为3.7×104Bq, 7.4×104Bq, 14.8×104Bq, 22.2×104Bq.碘-131诱发肿痛实际注入活度在2.37×104Bq以下,碘-125的为7.4×104以下.诱发的肿瘤以甲状腺肿瘤为主,其次为垂体肿瘤. 相似文献
54.
Oncocytosis and oncocytomas have attracted attention because on the one hand there have been reports of the favourable prognosis and generally benign nature of oncocytic tumours, while on the other hand, Hurthle cell change in thyroid neoplasms have been reported to be correlated with aggressive biological behaviour and a significantly worse clinical course. Presently, there appear to be two schools of thought on the significance of oncocytosis: (i) a process where there is redifferentiation of cells with involvement in the pathogenesis of cancer; and (ii) a compensatory process for ‘functional exhaustion’ of the cell. Many aspects of oncocytosis seem unclear. In this study, transmission electron microscopy is used to demonstrate the presence of thyroid oncocytes in the hemithyroidectomy specimen of a patient with focal lymphocytic thyroiditis. Tissue sections from this specimen did not display preferential uptake of neutral red dye, a distinctive characteristic of M-phase cancer cells which was previously reported. The findings seem to suggest that oncocytes are not cells with distinctive proliferative potentials. If that were the case, then oncogenesis or cancer cell progression and oncocytosis may not be convergent processes. 相似文献
55.
一个RET原癌基因Met918Thr突变的多发性内分泌腺瘤病Ⅱb家系报道 总被引:1,自引:0,他引:1
目的 检测一个多发性内分泌腺瘤病(MEN)Ⅱb家系的RET原癌基因突变。方法 提取患者及其父母的外周血基因组DNA,对RET原癌基因第16外显子进行聚合酶链反应(PCR),将PCR扩增产物进行直接基因测序和限制性内切酶分析。结果 检测到患者RET原癌基因第16外显子918密码子存在ATG(Met)/ACG(Thr)点突变,而在患者父母中未检测到该突变。结论 通过对MENⅡb患者及其父母的基因筛查发现,该患者点突变是杂合子错义突变。该疾病的诊断达到了基因水平。 相似文献
56.
57.
Anecdotal reports suggest that dysgeusia may be related to a variety of systemic factors, including bladder outflow obstruction. This is a hospital-based case-controlled study involving 111 patients who were admitted to urological wards for transurethral resection of the prostate for benign prostatic disease with age- and sex-matched control of 137 subjects. We used a semi-structured questionnaire by a trained interviewer at admission (preoperative), at the postoperative period and at follow-up between 4–6 months (median 5 months). Analysis used unpaired t-test and X2 test. The incidence of dysgeusia was 22% in the study group and 13% in the control group (P=N.S.). However, strikingly, the dysgeusia in the study group was relieved promptly by relief of urinary obstruction in 100% of cases and did not return within the follow-up period. The mechanism of the dysgeusia associated with dysuria in benign prostatic disease is unknown, but we suggest that the dysgeusia could be from the stress of dysuria or due to a release of an unknown chemical from the urinary tract or an overflow of neural impulse from pontine/cortical micturition centres to the taste centres. An association between dysgeusia and dysuria has not been described before. 相似文献
58.
本文报告2例系非甲亢危象及危象前期的甲状腺功能亢进(简称甲亢)患者,临床突出的症状是:频繁而又顽固的呕吐,例1导致了Mallory-Weiss征,服他巴唑60小时后呕吐明显缓解,96小时后呕吐完全停止。例2由于呕吐误诊为胃神经官能症,服他巴唑治疗一周后呕吐停止。甲亢性呕吐国内未见报告,本文对呕吐的机制进行了分析探讨。 相似文献
59.
60.
目的:探讨BPH切除术后前列腺癌的临床特点。方法:报告9例BPH切除术后前列腺癌患者的临床资料。前列腺癌发病距BPH手术时间为0.5~8年,平均4.6年。患者BPH术后主要因尿频、排尿困难、肉眼血尿或骨痛而再次就诊。血清PSA异常8例,前列腺结节5例,同位素扫描(ECT)骨转移1例。9例均行最大限度雄激素阻断治疗,1例骨痛者行辅助放疗。结果:7例获随访0.5~8年,其中死亡2例,病变稳定4例,病变进展1例。结论:BPH切除术后的病例仍有发生前列腺癌可能,术后应定期随访,及早发现术后前列腺癌。血清PSA、直肠指检及前列腺穿刺活检是BPH术后前列腺癌诊断的主要方法;早期可行前列腺癌根治术,晚期或转移者则以内分泌治疗为主。 相似文献